<DOC>
	<DOC>NCT01326910</DOC>
	<brief_summary>This three week study will be conducted to determine the safety and efficacy of an over-the-counter (OTC) cream in children with mild to moderate atopic dermatitis.</brief_summary>
	<brief_title>Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema</brief_title>
	<detailed_description>The objective of this trial is to evaluate the efficacy and safety of an OTC colloidal oatmeal skin protectant cream in children with mild to moderate AD in comparison to that of EpiCeramÂ®</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Children ages 6 mo 18 years Any ethnicity Diagnosed with atopic dermatitis (AD) per HanifinRajka criteria Mild to moderate atopic dermatitis per RajkaLangeland severity index Willing to use only provided cream and body wash for duration of study Known sensitivity to investigational products Pregnant or breastfeeding Severe AD per RajkaLangeland severity index AD requiring class I (super potent) or class II or III (potent) topical steroids Requires greater than 2.0 g inhaled or intranasal corticosteroids Other skin conditions which may interfere with the scoring of AD</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Eczema</keyword>
</DOC>